Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nevro Corp (NVRO)
NYSE:NVRO
Holding NVRO?
Track your performance easily
NVRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.92 - $22.53
Previous Close$4.07
Volume330.02K
Average Volume (3M)521.82K
Market Cap
$152.51M
Enterprise Value$122.06M
Total Cash (Recent Filing)$277.04M
Total Debt (Recent Filing)$246.59M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Feb 19, 2025EPS Estimate
-$0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.89
Shares Outstanding37,471,622
10 Day Avg. Volume411,846
30 Day Avg. Volume521,816
Standard Deviation0.14
R-Squared0.10
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.56
Price to Sales (P/S)0.36
Price to Cash Flow (P/CF)14.00
P/FCF Ratio5.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.29
Enterprise Value/Gross Profit0.42
Enterprise Value/Ebitda-5.56
Forecast
1Y Price Target
$5.38Price Target Upside29.64% Upside
Rating ConsensusHold
Number of Analyst Covering11
Nevro Corp News
PremiumCompany Announcements
Nevro Corp. Reports Strong Q3 2024 Financial Performance
PremiumCompany Announcements
Nevro Corp’s Market Cap Challenges: Impairment Risks and Investor ConcernsBulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted EBITDA came in much better than expected, showing the benefits of cost-cutting initiatives.
Market StrategyThe company received FDA approval and has begun a limited market release of HFX iQ with HFX AdaptivAI, which improves patient care efficiency.
Product DevelopmentHFX iQ AdaptivAI US approval represents an important step not only in stabilizing revenue growth, but further improving NVRO's margin profile.
Bears Say
Financial PerformanceIt is still hard to see a path to positive operating income, even with recent cost rationalization.
Market CompetitionRevenues are down due to strong competition from closed-loop technology.
Revenue GuidanceSales came in below expectations, and full year guidance was cut, calling for double-digit declines in sales and a significantly expanded EBITDA loss.
---
Ownership Overview
5.21% Insiders
22.37% Mutual Funds
53.71% Other Institutional Investors
7.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVRO FAQ
What was Nevro Corp’s price range in the past 12 months?
Nevro Corp lowest stock price was $3.92 and its highest was $22.52 in the past 12 months.
What is Nevro Corp’s market cap?
Currently, no data Available
When is Nevro Corp’s upcoming earnings report date?
Nevro Corp’s upcoming earnings report date is Feb 19, 2025 which is in 60 days.
How were Nevro Corp’s earnings last quarter?
Nevro Corp released its earnings results on Nov 11, 2024. The company reported -$0.41 earnings per share for the quarter, beating the consensus estimate of -$0.815 by $0.405.
Is Nevro Corp overvalued?
According to Wall Street analysts Nevro Corp’s price is currently Undervalued.
Does Nevro Corp pay dividends?
Nevro Corp does not currently pay dividends.
What is Nevro Corp’s EPS estimate?
Nevro Corp’s EPS estimate is -$0.78.
How many shares outstanding does Nevro Corp have?
Nevro Corp has 37,471,622 shares outstanding.
What happened to Nevro Corp’s price movement after its last earnings report?
Nevro Corp reported an EPS of -$0.41 in its last earnings report, beating expectations of -$0.815. Following the earnings report the stock price went down -4.887%.
Which hedge fund is a major shareholder of Nevro Corp?
Among the largest hedge funds holding Nevro Corp’s share is Engaged Capital LLC. It holds Nevro Corp’s shares valued at 14M.
---
Nevro Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.38 (29.64% Upside)
$5.38 (29.64% Upside)
Blogger Sentiment
Bullish
NVRO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.28%
12-Months-Change
Fundamentals
Return on Equity
-24.78%
Trailing 12-Months
Asset Growth
6.07%
Trailing 12-Months
Company Description
Nevro Corp
Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
---
NVRO Company Deck
---
NVRO Earnings Call
Q3 2024
0:00 / 0:00
---
NVRO Stock 12 Month Forecast
Average Price Target
$5.38
▲(29.64% Upside)
Technical Analysis
Best Analysts Covering NVRO
1 Year
1 Year Success Rate
10/14 ratings generated profit
1 Year Average Return
+32.04%
assigned a sell rating last month
Copying Adam Maeder's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +32.04% per trade.
---